Karl Karlsson

Karl Alexius Tiger Karlsson is the founder of Bluefish Pharmaceuticals AB, founded in 2005, where he held the titles of President, Chief Executive Officer & Director until 2020, and Newbury Pharmaceuticals AB, founded in 2020, where he previously held the title of Executive Chairman.
He is currently a Director at Alsakali Equity AB. Karlsson's former job experience includes being the Chief Executive Officer at Rda Interactive LLC from 2002 to 2002, where he worked from 1997 to 2002.
Karlsson received an MBA from Harvard University.